Area of research
Public Health, Environmental and Occupational Health · Pediatrics, Perinatology and Child Health
Research interest
Research focused on Minimal residual disease and Cumulative incidence, with related work in Oncology, Prednisone, Imatinib. Notable publications include 'Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000', 'Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts', and 'IKZF1 status as a prognostic feature in BCR-ABL1–positive childhood ALL'.
Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey
Correction: Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey
Are there any benefits of prolonged hypothermic oxygenated perfusion?: Results from a national retrospective study
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial
Improving outcomes of in situ split liver transplantation in Italy over the last 25 years
Frailty and post-operative delirium influence on functional status in patients with hip fracture: the GIOG 2.0 study
Early Onset Delirium During Hospitalization Increases In-Hospital and Postdischarge Mortality in COVID-19 Patients
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120
Patterns of recurrences in sinonasal cancers undergoing an endoscopic surgery-based treatment: Results of the MUSES* on 940 patients
PAX5 Fusion Genes are Frequent in Poor Risk Childhood Acute Lymphoblastic Leukaemia and Can Be Targeted with BIBF1120
Delirium Increases In-Hospital and Post-Discharge Mortality in COVID-19 Patients: The FRACOVID Multicenter Prospective Study
Machine learning in primary biliary cholangitis: A novel approach for risk stratification
Study protocol: understanding the pathophysiologic mechanisms underlying delirium in older people undergoing hip fracture surgery
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis
Recurrent genetic fusions redefine <i>MLL </i>germ line acute lymphoblastic leukemia in infants
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patients
Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial
The presence of mutated and deleted <scp>PTEN</scp> is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with <scp>AIEOP</scp>‐<scp>BFM ALL</scp> protocols
Long-term survivors of childhood cancer: cure and care—the Erice Statement (2006) revised after 10 years (2016)
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells
CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)